EAU Guidelines on Assessment and Nonsurgical Management of Urinary Incontinence

Aim To evaluate the benefits of a newly established checklist form of behavioral therapy for overactive bladder (OAB). Methods Of a total of 180 patients suffering eight or more micturitions, two or more nocturia, seven or more urgency, or four more urinary urgency incontinence (UUI) episodes per day according to a 3‐day bladder diary, 155 were randomly divided into four groups. Group I (n = 29) patients were instructed to apply only behavioral therapy as a written guideline and group II (n = 27) patients were instructed to apply behavioral therapy with a written checklist. Group III (n = 26) patients received medical treatment plus behavioral therapy without a checklist. Group IV (n = 28) patients received medical treatment with a written checklist over a 6‐month period. Results A total of 110 participants completed the study period. The demographic data and baseline voiding parameters such as frequency, urgency, nocturia, and UUI of the participants in all four groups were similar (P > 0.05 for all). At the end of the study period, the highest rates of treatment response (64.3%) and adherence (85.7%) were determined for the patients with antimuscarinic drugs plus checklist. The persistence rate of patients using antimuscarinics with the checklist was higher than that of those using antimuscarinics plus a written guideline of behavioral therapy (75.4% vs 60.2%). Conclusion The effectiveness of behavioral therapy for OAB can be improved with this newly designed checklist. In addition, the adherence and persistence rate of medical treatment may also improve with the checklist used.

Section: Introductionmentioning

confidence: 99%

Using a checklist to increase the effectiveness of behavioral therapy for overactive bladder: A prospective randomized controlled trial

Kılınç¹,

Doluoğlu²,

Yıldız³

et al. 2019

“…To compare the burden of OAB in patients and define guidelines for treatment, consensus is necessary on the specific questionnaire to use. The EAU (European Association of Urology) and the ICS (International Continence Society) guidelines do not recommend specific questionnaires to use for OAB, but both professional organizations mention that it is important to use questionnaires validated in the language of use . The International Consortium for Health Outcome measurements (ICHOM) aims to improve value‐based healthcare by defining global standard sets of outcome measures for different conditions.…”

Section: Introductionmentioning

confidence: 99%

The validation of the Dutch OAB‐q SF: An overactive bladder symptom bother and health‐related quality of life short‐form questionnaire

Groenendijk

Scheepe

Noordhoff

et al. 2019

Aims The overactive bladder quality of life short‐form questionnaire (OAB‐q SF) evaluates both symptom bother and health‐related quality of life in patients with OAB, a highly prevalent disease. The objective of this study was to translate and validate a Dutch version of the OAB‐q SF. Methods The translation into Dutch and validation process of the OAB‐q SF was performed according to standardized guidelines. Patients with OAB who visited the department of Urology outpatient clinic completed the questionnaires OAB‐q SF, European Quality of life 5‐Dimension 5‐Level questionnaire (EQ‐5D‐5L), Urogenital Distress Inventory 6 (UDI‐6), and the International Consultation on Incontinence Questionnaire Overactive Bladder (ICIQ‐OAB) at baseline (test) and 2 weeks later (retest). A reference group from the department of Allergology outpatient clinic completed the same questionnaires once. The evaluated measurement properties included content validity, internal consistency, reproducibility, criterion validity, and construct validity. Results Fifty‐two patients were included in the study group and 51 references were included. The content validity was adequate and the internal consistency was excellent (Cronbach's α > 0.80). The reproducibility was good with intraclass correlation coefficients higher than 0.70. Patient's OAB‐q SF scores were moderately to strongly correlated with the UDI‐6, ICIQ‐OAB, and the EQ‐5D‐5L confirming the criterion validity. A good construct validity was demonstrated with significant higher scores of the OAB‐q SF score in patients compared to references. Conclusions The Dutch OAB‐q SF is a reliable and valid measure to evaluate symptom bother and health‐related quality of life in patients with OAB.

“…OAB is a clinical diagnosis which is mainly based on patient history and symptoms. International Consultation on Incontinence and European Association of Urology guidelines recommend 3‐day bladder diary within the context of diagnostic evaluation . However, bladder diary is sometimes ignored in routine practice due to a combination of patient‐ and physician‐related factors …”

Section: Introductionmentioning

confidence: 99%

“…Guidelines recommend conservative approaches (lifestyle modifications, behavioral therapy, etc.) and antimuscarinic drugs or mirabegron as the first‐ and second‐line treatment modalities, respectively . However, the application pattern of these treatments may vary among urologists.…”

Section: Introductionmentioning

confidence: 99%

The real‐life management of overactive bladder: Turkish Continence Society multicenter prospective cohort study with short‐term outcome

Zümrütbaş

Çitgez

Acar

et al. 2019

Introduction Turkish Continence Society aimed to analyze how overactive bladder (OAB) is being managed in routine practice by the urologists in Turkey. Material and methods Fourteen urology departments were randomly selected to represent the whole population in this multicenter study. An online data entry and storage software was created for patient recruitment and data assessment. A survey including demographic data, daily habits, lower urinary tract symptoms, and Turkish‐validated OAB‐V8 and ICIQ‐SF questionnaires were completed by all patients. Second part of the survey, including the questions about clinical evaluation and management of the patient, was completed by the treating physician. Results A total of 507 patients (394 female and 113 male) were included. Behavioral therapy was recommended to 73.2% of female and 81.4% of male patients although bladder diary was requested for 59.5% and 52.7% of the female and male patients, respectively. In the first visit, 86.1% of the female and 89.3% of the male patients were given antimuscarinics (P = .431). Antimuscarinic‐related side effects occurred in 94.9% and 88.9% of the female and male patients, respectively (P = .937). However, the rate of medical treatment change due to antimuscarinic‐related side effects was only 1.7% in female and 4.8% in male patients at the end of 4 months. Conclusions Behavioral therapy and antimuscarinics were the preferred initial treatment modalities of OAB in concordance with the guidelines. Despite guideline recommendations, bladder diaries were not utilized in half of the patients. Insufficient efficacy appeared to be the main reason for treatment modification.